Mucopolysaccharidosis type 2 (Hunter)
On ABGC's listListed on the ABGC Self-Study GuideLog in to starLast updated Nov 4, 2026
A boy has features similar to Hurler but without corneal clouding. He has distinctive ivory-colored skin lesions (pebbling) on the upper back and shoulders.
XLR; IDS (iduronate 2-sulfatase, a lysosomal enzyme that removes sulfate from heparan and dermatan sulfate). Loss-of-function variants, including deletions and rearrangements with the nearby IDSP1 pseudogene.
Iduronate 2-sulfatase releases sulfate from the iduronate sulfate residues of heparan sulfate and dermatan sulfate during their breakdown in the lysosome. Absent or reduced activity leaves both glycosaminoglycans undegraded, so they are stored throughout the body and raised in urine, the same pair as in MPS I. Corneal clouding, typical of MPS I, is only occasional here; ivory skin lesions on the upper back and arms are pathognomonic.
Variant class predicts the neurologic course:
- Gene deletions and complex rearrangements (about 17% of affected males) remove all enzyme and always give the neuronopathic form. A shared stretch of sequence with IDSP1, about 25 kb away, drives unequal recombination; a common inversion between the two is missed by sequencing, so rearrangement testing is needed when sequencing is normal.
- Variants that keep even very low or cell-type-specific activity can prevent the neuronal phenotype; c.1122C>T, which creates a new splice site, mostly gives non-neuronopathic disease.
Heterozygous females are usually unaffected and rarely manifest through skewed X-inactivation, which also makes enzyme activity unreliable for carrier testing. Idursulfase does not cross the blood-brain barrier, so it treats the body but not the brain.
Part of lysosomal glycosaminoglycan degradation.
Lysosomal degradation of heparan sulfate and dermatan sulfate, by enzymes that each cut a sugar or a sulfate from the end of the chain.
heparan sulfate, dermatan sulfate → lysosome → iduronate 2-sulfatase (the block; removes sulfate from iduronate) → further stepwise degradation → free sugars and sulfate
- Accumulates: heparan sulfate and dermatan sulfate, measured as raised urine GAGs; the enzyme assay must show another sulfatase normal, to exclude multiple sulfatase deficiency.
- Missing: the chain's breakdown products; the disease comes from storage and its effects on the cell.
- Workbook: 7.H. Mucopolysaccharidoses I and II
- Similar to MPS I, but corneal clouding is not a typical feature (occasional at most)
- Pebbled skin lesions (pathognomonic)
- Only X-linked MPS
- Severe and attenuated forms
- On RUSP (some states)
- Urine glycosaminoglycans: elevated dermatan sulfate and heparan sulfate
- Deficient iduronate-2-sulfatase enzyme activity (with a second sulfatase assay normal, to exclude multiple sulfatase deficiency)
- IDS molecular testing confirms diagnosis and identifies carriers (X-linked); useful for the large recurrent inversion/rearrangement
- Enzyme replacement therapy (idursulfase), HSCT
"Hun-Two-er" = MPS II: "Two" is hidden in "Hun-Two-er" (Hunter).
"Hunter sees clearly": Hunter syndrome (MPS II) has no corneal clouding (unlike Hurler). The hunter needs clear vision to aim. "Hunter ate the prey": iduronate-2-sulfatase removes a sulfate group.
"Hunt with Rocks/Pebbles": pebbled skin lesions on the upper back and shoulders are pathognomonic for MPS II. "Hunt Deer": Hunter has heparan + dermatan sulfate elevated in urine.
Only X-linked MPS: part of the HALO-M X-linked disorders: Hunter, Adrenoleukodystrophy, Lesch-Nyhan, OTC deficiency, Menkes.